General Information of Drug Off-Target (DOT) (ID: OTAEOACS)

DOT Name Developmental pluripotency-associated protein 4 (DPPA4)
Gene Name DPPA4
Related Disease
Advanced cancer ( )
Colon cancer ( )
Colon carcinoma ( )
Colorectal carcinoma ( )
Head-neck squamous cell carcinoma ( )
Neoplasm ( )
Non-small-cell lung cancer ( )
Seminoma ( )
UniProt ID
DPPA4_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF14047 ; PF14049
Sequence
MLRGSASSTSMEKAKGKEWTSTEKSREEDQQASNQPNSIALPGTSAKRTKEKMSIKGSKV
LCPKKKAEHTDNPRPQKKIPIPPLPSKLPPVNLIHRDILRAWCQQLKLSSKGQKLDAYKR
LCAFAYPNQKDFPSTAKEAKIRKSLQKKLKVEKGETSLQSSETHPPEVALPPVGEPPALE
NSTALLEGVNTVVVTTSAPEALLASWARISARARTPEAVESPQEASGVRWCVVHGKSLPA
DTDGWVHLQFHAGQAWVPEKQEGRVSALFLLPASNFPPPHLEDNMLCPKCVHRNKVLIKS
LQWE
Function May be involved in the maintenance of active epigenetic status of target genes. May inhibit differentiation of embryonic cells into a primitive ectoderm lineage.
Reactome Pathway
Zygotic genome activation (ZGA) (R-HSA-9819196 )
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation (R-HSA-2892247 )

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Colon cancer DISVC52G Strong Altered Expression [2]
Colon carcinoma DISJYKUO Strong Altered Expression [2]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [2]
Head-neck squamous cell carcinoma DISF7P24 Strong Biomarker [3]
Neoplasm DISZKGEW Strong Biomarker [4]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [4]
Seminoma DIS3J8LJ Strong Altered Expression [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Developmental pluripotency-associated protein 4 (DPPA4). [6]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Developmental pluripotency-associated protein 4 (DPPA4). [7]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Developmental pluripotency-associated protein 4 (DPPA4). [8]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Developmental pluripotency-associated protein 4 (DPPA4). [10]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Developmental pluripotency-associated protein 4 (DPPA4). [11]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Developmental pluripotency-associated protein 4 (DPPA4). [9]
------------------------------------------------------------------------------------

References

1 Genomic functions of developmental pluripotency associated factor 4 (Dppa4) in pluripotent stem cells and cancer.Stem Cell Res. 2018 Aug;31:83-94. doi: 10.1016/j.scr.2018.07.009. Epub 2018 Jul 19.
2 Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.J Exp Clin Cancer Res. 2015 Jun 11;34(1):60. doi: 10.1186/s13046-015-0176-z.
3 Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.J Oral Pathol Med. 2016 May;45(5):329-37. doi: 10.1111/jop.12372. Epub 2015 Oct 5.
4 High developmental pluripotencyassociated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in nonsmallcell lung cancer.Mol Med Rep. 2019 Jul;20(1):445-454. doi: 10.3892/mmr.2019.10272. Epub 2019 May 22.
5 Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures.Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17763-8. doi: 10.1073/pnas.0509082102. Epub 2005 Nov 23.
6 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
7 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
8 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
11 Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335:122359. doi: 10.1016/j.envpol.2023.122359. Epub 2023 Aug 9.